Clinical Trial Update: AAV2-GDNF for Advanced Parkinson s Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AAV2-GDNF gene therapy for advanced Parkinson's disease has completed its Phase 1 portion. The study is sponsored by the National Ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AAV2-GDNF

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED